By Purvi Agarwal and Pranav Kashyap
(Reuters) -London’s FTSE 100 fell for the third consecutive day on Thursday as GSK dropped after the U.S. public health agency narrowed the scope of the drugmaker’s RSV vaccine, while investors awaited key U.S. and domestic economic data.
The benchmark FTSE 100 was down 0.6% to 8,179.68 points.
The pharma sector was weighed down by the 4.6% drop in GSK after the U.S. CDC on Wednesday narrowed its recommendation for the use of respiratory syncytial virus vaccines in older adults this year and held off on recommending their use for adults under the age of…